Last updated: 13.02.2014

Address: Magdalen Centre The Oxford Science Park Oxford OX4 4GA,United Kingdom

Tel: +44 (0)1865 784574


Company description

Circassia is a specialty biopharmaceutical company focused on developing world-class immunotherapies. These include a new class of T-cell vaccines designed to treat a broad range of allergies, and therapies to combat autoimmune conditions such as rheumatoid arthritis and psoriasis. The Company has made rapid progress since its establishment in 2006, and several of its products are currently in mid- to late-stage development, having successfully completed a number of phase II clinical studies.

Products and services

Circassia has a broad portfolio of immuno-based therapies, with many currently progressing through clinical development. The company has completed a number of successful phase II studies and plans to advance several products into the final stage of development in the near future.


We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here